tiprankstipranks
pc:iantr

Iantrek

Iantrek is a medical technology company focused on bio-interventional ophthalmic surgery (BIOS) for chronic eye diseases, particularly glaucoma. The company develops minimally invasive surgical technologies, including instrumentation and biologic tissue solutions, to restore natural ocular fluid outflow pathways and enable micro-interventional procedures for improved patient outcomes.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$30M
Total Amount Raised$30M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$30M
Latest Funding Amount$30M
Latest Funding RoundGrowth Round
Latest Funding RoundGrowth Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 28, 2026
Growth Round
$30.00M

Investors

Investor Name
Funding Round

Related News and Analysis